• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Hepatology International >Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B
【24h】

Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B

机译：替比夫定联合阿德福韦与阿德福韦单药治疗HBeAg阳性，拉米夫定耐药的慢性乙型肝炎

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Lamivudine (LAM) resistance is common on lamivudine monotherapy for chronic hepatitis B. This study examined the safety and efficacy of telbivudine (LDT) given with adefovir (ADV) versus ADV monotherapy in patients with chronic, lamivudine-resistant HBV infection.
机译：拉米夫定单药治疗慢性乙型肝炎对拉米夫定（LAM）耐药是常见的。这项研究检查了阿德福韦（ADV）相对于ADV单药治疗的替比夫定（LDT）与慢性拉米夫定耐药性HBV感染患者的安全性和有效性。

著录项

  • 来源
    《Hepatology International》 |2012年第4期|p.696-706|共11页
  • 作者

    Sang-Hoon Ahn; Young-Oh Kweon; Seung-Woon Paik; Joo-Hyun Sohn; Kwan-Sik Lee; Dong Joon Kim; Teerha Piratvisuth; Man Fung Yuen; Anuchit Chutaputti; You-Chen Chao; Aldo Trylesinski; Claudio Avila;

  • 作者单位

    Department of Internal Medicine, Yonsei University College of Medicine, 250 Seongsanno, Seoul, South Korea;

    The Kyungpook National University Hospital, Daegu, Korea;

    Department of Medicine/Gastroenterology, Samsung Medical Centre, Seoul, Korea;

    Division of Gastroenterology, Hanyang University Guri Hospital, Gyeonggi-do, Suwon, Korea;

    Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea;

    Hallym University Sacred Heart Hospital, Chuncheon, Korea;

    NKC Institute of Gastroenterology and Hepatology, Songklanagarind Hospital, Prince of Songkla University, Hat Yai, Thailand;

    Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong;

    Phramongkutklao Hospital, Bangkok, Thailand;

    Tri-Service General Hospital, Taipei, Taiwan, R.O.C;

    Novartis Pharma AG, Basel, Switzerland;

    Novartis Pharma AG, Basel, Switzerland;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Telbivudine; Adefovir; Lamivudine-resistant; Hepatitis B;

    机译：替比夫定;阿德福韦;拉米夫定耐药;乙型肝炎;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号